-
Sequencing Data of HGSC patient-derived cell lines and organoids
Study
EGAS00001006557
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures (Hipo_021)
Study
EGAS00001006629
-
Identification of neoantigen from MSI-CRC patient derived organoids and its application for targeting by autologous T cells
Study
EGAS00001006633
-
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling (hipo_021)
Study
EGAS00001006747
-
Genomic Analysis of a Metastatic Fusion-negative Embryonal Rhabdomyosarcoma
Study
EGAS00001006946
-
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune-editing in lung cancer
Study
EGAS00001006298
-
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Study
EGAS00001006553
-
GENOMIC MUTATION LANDSCAPE OF SKIN CANCERS FROM DNA REPAIR-DEFICIENT XERODERMA PIGMENTOSUM PATIENTS
Study
EGAS00001006732
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___visium
Study
EGAS00001006045
-
Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies unique proteotypes associated with patient outcomes
Study
EGAS00001006068
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123
-
Shallow nanopore RNA sequencing enables transcriptome profiling for precision cancer medicine (Hipo_021)
Study
EGAS00001006317
-
A machine learning classifier for DNA repair defects using plasma DNA
Study
EGAS00001007006
-
Quantitative analysis of a novel DNA hypermethylation panel for lung cancer diagnosis using bronchial specimens
Study
EGAS00001007089
-
Point-of-care monitoring of head and neck cancer treatment response and recurrence development using nanopore-based ctDNA consensus sequencing
Study
EGAS00001007090
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Human lymphoma plasma cfRNA - raw data
Study
EGAS00001007127
-
Cachexia - Non-Cachexia Metagenome Analysis
Study
EGAS00001007156
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
MD Anderson Cancer Center Data Access Committee
Dac
EGAC00001002802
-
ctDNA to predict risk of progression and death after trifluridin/tipiracil therapy
Study
EGAS00001006883
-
RNA sequencing data of 257 samples from 106 patients with HR+/HER2- breast cancer treated with AC plus paclitaxel or letrozole plus ribociclib (SOLTI-1402 CORALLEEN trial)
Study
EGAS00001007060
-
Evaluation of triple negative breast cancer with heterogeneous immune infiltration
Study
EGAS00001007159
-
Tumor microenvironment study of ovarian granulosa cell tumors
Study
EGAS00001006478
-
Clonal architecture and genomic features of smoking versus non-smoking oncogene-driven East-Asian non-small cell lung cancer
Study
EGAS00001006942
-
Genomic profiling of Rare Tumors
Study
EGAS00001007103
-
Enhanced detection of MRD with cfDNA Fragmentomics.
Study
EGAS00001007192
-
Ovarian Cancer Laboratory, University of Oxford
Dac
EGAC00001000518
-
Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital
Dac
EGAC00001003206
-
Submission 17 - study_title 1
Study
EGAS50000000021
-
Human primary and metastatic colorectal cancer (CRC) samples
Dac
EGAC00001002954
-
Treated and control Patient Derived Xenografts of colorectal cancer (CRC) samples
Dac
EGAC00001003073
-
Submission 14 - study_title 1
Study
EGAS50000000044
-
The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study DAC
Dac
EGAC00001003055
-
TRACERx Non-small cell lung cancer
Dac
EGAC00001000632
-
National Cancer Center Singapore
Dac
EGAC00001001550
-
Pan Cancer Plasma cfRNA DAC
Dac
EGAC00001003176
-
Wilms_Tumour_organoid_sequencing_WGS
Study
EGAS00001002692
-
Melanoma_brain_metastases
Study
EGAS00001002107
-
The_mutational_landscape_of_recurrent_Glioblastome_multiforme
Study
EGAS00001001764
-
Targeted_analysis_of_chondrosarcoma_cancer_genes
Study
EGAS00001001765
-
ENU_LS_411N_TripleTherapy
Study
EGAS00001001777
-
ENU_HT_29_BRAF_Triple_Therapy_Clones
Study
EGAS00001001778
-
V2_panel_bait_design_test
Study
EGAS00001001780
-
V4_panel_bait_design_test
Study
EGAS00001001808
-
Targeted_gene_screen_of_drug_resistant_organoids
Study
EGAS00001001797
-
V2_Colorectal_panel_test
Study
EGAS00001001806
-
V4_Colorectal_panel_test
Study
EGAS00001001807
-
Integration of genomics and histology reveals diagnosis and effective therapy of refractory cancer of unknown primary with PDL1 amplification (H021)
Study
EGAS00001001846
-
Low_input_LC__ISC_
Study
EGAS00001001856